MedPath

Hidradenitis Suppurativa Written Action Plan

Not Applicable
Terminated
Conditions
Hidradenitis Suppurativa
Interventions
Behavioral: Verbal consultation
Behavioral: Written Action Plan
Registration Number
NCT04230291
Lead Sponsor
University of Arizona
Brief Summary

This study is being conducted to evaluate if a written action plan for hidradenitis suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding of the condition and how to manage the condition on a daily basis compared to a routine verbal consultation.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • Has a diagnosis of HS
Exclusion Criteria
  • Has been exposed to a written action plan for HS before

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Verbal Consultation, then Written Action PlanVerbal consultationCONTROL GROUP 1. Survey A 2. Routine clinic visit 3. Verbal consultation only 4. Survey B 5. Verbal consultation AND Written Action Plan 6. Survey C
Verbal Consultation, then Written Action PlanWritten Action PlanCONTROL GROUP 1. Survey A 2. Routine clinic visit 3. Verbal consultation only 4. Survey B 5. Verbal consultation AND Written Action Plan 6. Survey C
Written Action PlanWritten Action PlanINTERVENTION GROUP 1. Survey A 2. Routine clinic visit 3. Verbal consultation AND Written Action Plan 4. Survey C
Primary Outcome Measures
NameTimeMethod
Visits to high-cost care settings12 months

Number of visits to ER, urgent care, or hospitalizations because of HS

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Arizona

🇺🇸

Tucson, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath